Global Glottic Cancer Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: G000CD1FC8C5EN
QYResearch

Abstracts

This report focuses on the global Glottic Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glottic Cancer Treatment development in North America, Europe and Asia-Pacific.
The key players covered in this study

• Novartis
• Eli Lilly
• Cipla
• Amgen
• Biocon
• Bristol-Myers Squibb
• Merck
• Pfizer
• Celgene
• Roche
• Teva

Market segment by Type, the product can be split into

• Surgical Treatment
• Drug Treatment

Market segment by Application, split into

• Hospital
• Clinic
• Ambulatory Surgical Center
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Glottic Cancer Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Glottic Cancer Treatment development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Glottic Cancer Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Glottic Cancer Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Glottic Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Surgical Treatment
  1.4.3 Drug Treatment
1.5 Market by Application
  1.5.1 Global Glottic Cancer Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Ambulatory Surgical Center
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Glottic Cancer Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Glottic Cancer Treatment Industry
    1.6.1.1 Glottic Cancer Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Glottic Cancer Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Glottic Cancer Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Glottic Cancer Treatment Market Perspective (2015-2026)
2.2 Glottic Cancer Treatment Growth Trends by Regions
  2.2.1 Glottic Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Glottic Cancer Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Glottic Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Glottic Cancer Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Glottic Cancer Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Glottic Cancer Treatment Players by Market Size
  3.1.1 Global Top Glottic Cancer Treatment Players by Revenue (2015-2020)
  3.1.2 Global Glottic Cancer Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Glottic Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Glottic Cancer Treatment Market Concentration Ratio
  3.2.1 Global Glottic Cancer Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Glottic Cancer Treatment Revenue in 2019
3.3 Glottic Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Glottic Cancer Treatment Product Solution and Service
3.5 Date of Enter into Glottic Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Glottic Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Glottic Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 GLOTTIC CANCER TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Glottic Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Glottic Cancer Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Glottic Cancer Treatment Market Size (2015-2020)
6.2 Glottic Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Glottic Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Glottic Cancer Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Glottic Cancer Treatment Market Size (2015-2020)
7.2 Glottic Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Glottic Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Glottic Cancer Treatment Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Glottic Cancer Treatment Market Size (2015-2020)
8.2 Glottic Cancer Treatment Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Glottic Cancer Treatment Market Size by Type (2015-2020)
8.4 Asia-Pacific Glottic Cancer Treatment Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Novartis
  9.1.1 Novartis Company Details
  9.1.2 Novartis Business Overview and Its Total Revenue
  9.1.3 Novartis Glottic Cancer Treatment Introduction
  9.1.4 Novartis Revenue in Glottic Cancer Treatment Business (2015-2020))
  9.1.5 Novartis Recent Development
9.2 Eli Lilly
  9.2.1 Eli Lilly Company Details
  9.2.2 Eli Lilly Business Overview and Its Total Revenue
  9.2.3 Eli Lilly Glottic Cancer Treatment Introduction
  9.2.4 Eli Lilly Revenue in Glottic Cancer Treatment Business (2015-2020)
  9.2.5 Eli Lilly Recent Development
9.3 Cipla
  9.3.1 Cipla Company Details
  9.3.2 Cipla Business Overview and Its Total Revenue
  9.3.3 Cipla Glottic Cancer Treatment Introduction
  9.3.4 Cipla Revenue in Glottic Cancer Treatment Business (2015-2020)
  9.3.5 Cipla Recent Development
9.4 Amgen
  9.4.1 Amgen Company Details
  9.4.2 Amgen Business Overview and Its Total Revenue
  9.4.3 Amgen Glottic Cancer Treatment Introduction
  9.4.4 Amgen Revenue in Glottic Cancer Treatment Business (2015-2020)
  9.4.5 Amgen Recent Development
9.5 Biocon
  9.5.1 Biocon Company Details
  9.5.2 Biocon Business Overview and Its Total Revenue
  9.5.3 Biocon Glottic Cancer Treatment Introduction
  9.5.4 Biocon Revenue in Glottic Cancer Treatment Business (2015-2020)
  9.5.5 Biocon Recent Development
9.6 Bristol-Myers Squibb
  9.6.1 Bristol-Myers Squibb Company Details
  9.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  9.6.3 Bristol-Myers Squibb Glottic Cancer Treatment Introduction
  9.6.4 Bristol-Myers Squibb Revenue in Glottic Cancer Treatment Business (2015-2020)
  9.6.5 Bristol-Myers Squibb Recent Development
9.7 Merck
  9.7.1 Merck Company Details
  9.7.2 Merck Business Overview and Its Total Revenue
  9.7.3 Merck Glottic Cancer Treatment Introduction
  9.7.4 Merck Revenue in Glottic Cancer Treatment Business (2015-2020)
  9.7.5 Merck Recent Development
9.8 Pfizer
  9.8.1 Pfizer Company Details
  9.8.2 Pfizer Business Overview and Its Total Revenue
  9.8.3 Pfizer Glottic Cancer Treatment Introduction
  9.8.4 Pfizer Revenue in Glottic Cancer Treatment Business (2015-2020)
  9.8.5 Pfizer Recent Development
9.9 Celgene
  9.9.1 Celgene Company Details
  9.9.2 Celgene Business Overview and Its Total Revenue
  9.9.3 Celgene Glottic Cancer Treatment Introduction
  9.9.4 Celgene Revenue in Glottic Cancer Treatment Business (2015-2020)
  9.9.5 Celgene Recent Development
9.10 Roche
  9.10.1 Roche Company Details
  9.10.2 Roche Business Overview and Its Total Revenue
  9.10.3 Roche Glottic Cancer Treatment Introduction
  9.10.4 Roche Revenue in Glottic Cancer Treatment Business (2015-2020)
  9.10.5 Roche Recent Development
9.11 Teva
  10.11.1 Teva Company Details
  10.11.2 Teva Business Overview and Its Total Revenue
  10.11.3 Teva Glottic Cancer Treatment Introduction
  10.11.4 Teva Revenue in Glottic Cancer Treatment Business (2015-2020)
  10.11.5 Teva Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Glottic Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Glottic Cancer Treatment Revenue
Table 3. Ranking of Global Top Glottic Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Glottic Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgical Treatment
Table 6. Key Players of Drug Treatment
Table 7. COVID-19 Impact Global Market: (Four Glottic Cancer Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Glottic Cancer Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Glottic Cancer Treatment Players to Combat Covid-19 Impact
Table 12. Global Glottic Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Glottic Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Glottic Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Glottic Cancer Treatment Market Share by Regions (2015-2020)
Table 16. Global Glottic Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Glottic Cancer Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Glottic Cancer Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Glottic Cancer Treatment Players
Table 23. Global Glottic Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Glottic Cancer Treatment Market Share by Players (2015-2020)
Table 25. Global Top Glottic Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glottic Cancer Treatment as of 2019)
Table 26. Global Glottic Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Glottic Cancer Treatment Product Solution and Service
Table 29. Date of Enter into Glottic Cancer Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Glottic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Glottic Cancer Treatment Market Size Share by Type (2015-2020)
Table 33. Global Glottic Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Glottic Cancer Treatment Market Size Share by Application (2015-2020)
Table 35. Global Glottic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Glottic Cancer Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Glottic Cancer Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Glottic Cancer Treatment Market Share (2019-2020)
Table 39. North America Glottic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Glottic Cancer Treatment Market Share by Type (2015-2020)
Table 41. North America Glottic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Glottic Cancer Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Glottic Cancer Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Glottic Cancer Treatment Market Share (2019-2020)
Table 45. Europe Glottic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Glottic Cancer Treatment Market Share by Type (2015-2020)
Table 47. Europe Glottic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Glottic Cancer Treatment Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Glottic Cancer Treatment Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Glottic Cancer Treatment Market Share (2019-2020)
Table 51. Asia-Pacific Glottic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Glottic Cancer Treatment Market Share by Type (2015-2020)
Table 53. Asia-Pacific Glottic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Glottic Cancer Treatment Market Share by Application (2015-2020)
Table 55. Novartis Company Details
Table 56. Novartis Business Overview
Table 57. Novartis Product
Table 58. Novartis Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 59. Novartis Recent Development
Table 60. Eli Lilly Company Details
Table 61. Eli Lilly Business Overview
Table 62. Eli Lilly Product
Table 63. Eli Lilly Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 64. Eli Lilly Recent Development
Table 65. Cipla Company Details
Table 66. Cipla Business Overview
Table 67. Cipla Product
Table 68. Cipla Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 69. Cipla Recent Development
Table 70. Amgen Company Details
Table 71. Amgen Business Overview
Table 72. Amgen Product
Table 73. Amgen Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 74. Amgen Recent Development
Table 75. Biocon Company Details
Table 76. Biocon Business Overview
Table 77. Biocon Product
Table 78. Biocon Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 79. Biocon Recent Development
Table 80. Bristol-Myers Squibb Company Details
Table 81. Bristol-Myers Squibb Business Overview
Table 82. Bristol-Myers Squibb Product
Table 83. Bristol-Myers Squibb Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Company Details
Table 93. Pfizer Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. Celgene Company Details
Table 96. Celgene Business Overview
Table 97. Celgene Product
Table 98. Celgene Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 99. Celgene Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche Product
Table 103. Roche Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 104. Roche Recent Development
Table 105. Teva Company Details
Table 106. Teva Business Overview
Table 107. Teva Product
Table 108. Teva Revenue in Glottic Cancer Treatment Business (2015-2020) (Million US$)
Table 109. Teva Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Glottic Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgical Treatment Features
Figure 3. Drug Treatment Features
Figure 4. Global Glottic Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Ambulatory Surgical Center Case Studies
Figure 8. Others Case Studies
Figure 9. Glottic Cancer Treatment Report Years Considered
Figure 10. Global Glottic Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Glottic Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Glottic Cancer Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Glottic Cancer Treatment Market Share by Players in 2019
Figure 15. Global Top Glottic Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glottic Cancer Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Glottic Cancer Treatment Revenue in 2019
Figure 17. North America Glottic Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Glottic Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Asia-Pacific Glottic Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. Novartis Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 22. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Eli Lilly Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 24. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Cipla Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 26. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Amgen Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 28. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Biocon Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 30. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bristol-Myers Squibb Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Merck Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 36. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Celgene Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 38. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Roche Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 40. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Teva Revenue Growth Rate in Glottic Cancer Treatment Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed